DK0937100T3 - En ny polymorfisk krystallinsk form af fluticasonpropionat, fremgangsmåder til fremstilling deraf og farmaceutiske præparater deraf - Google Patents
En ny polymorfisk krystallinsk form af fluticasonpropionat, fremgangsmåder til fremstilling deraf og farmaceutiske præparater derafInfo
- Publication number
- DK0937100T3 DK0937100T3 DK97909496T DK97909496T DK0937100T3 DK 0937100 T3 DK0937100 T3 DK 0937100T3 DK 97909496 T DK97909496 T DK 97909496T DK 97909496 T DK97909496 T DK 97909496T DK 0937100 T3 DK0937100 T3 DK 0937100T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystalline form
- polymorphic crystalline
- fluticasone propionate
- new polymorphic
- preparation
- Prior art date
Links
- 229960000289 fluticasone propionate Drugs 0.000 title abstract 2
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Disintegrating Or Milling (AREA)
- Formation And Processing Of Food Products (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9622173.4A GB9622173D0 (en) | 1996-10-24 | 1996-10-24 | Particulate Products |
PCT/GB1997/002929 WO1998017676A1 (en) | 1996-10-24 | 1997-10-23 | A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0937100T3 true DK0937100T3 (da) | 2003-09-01 |
Family
ID=10801903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97909496T DK0937100T3 (da) | 1996-10-24 | 1997-10-23 | En ny polymorfisk krystallinsk form af fluticasonpropionat, fremgangsmåder til fremstilling deraf og farmaceutiske præparater deraf |
Country Status (13)
Country | Link |
---|---|
US (1) | US6406718B1 (es) |
EP (1) | EP0937100B1 (es) |
JP (1) | JP2001502350A (es) |
AT (1) | ATE240345T1 (es) |
AU (1) | AU4717197A (es) |
CA (1) | CA2269134C (es) |
DE (1) | DE69722023T2 (es) |
DK (1) | DK0937100T3 (es) |
ES (1) | ES2198555T3 (es) |
GB (1) | GB9622173D0 (es) |
PE (1) | PE68099A1 (es) |
PT (1) | PT937100E (es) |
WO (1) | WO1998017676A1 (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9806462D0 (en) * | 1998-03-26 | 1998-05-27 | Glaxo Group Ltd | Improved compositions for inhalation |
GB9828204D0 (en) * | 1998-12-21 | 1999-02-17 | Smithkline Beecham Plc | Process |
US6630121B1 (en) | 1999-06-09 | 2003-10-07 | The Regents Of The University Of Colorado | Supercritical fluid-assisted nebulization and bubble drying |
US20020133032A1 (en) * | 2000-02-25 | 2002-09-19 | Jufang Barkalow | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
OA12394A (en) | 2000-08-05 | 2004-07-09 | Glaxo Group Ltd | 6.Alpha-,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fuoromethyl ester as an anti-inflammatory agent. |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
GB0021927D0 (en) * | 2000-09-07 | 2000-10-25 | Glaxo Group Ltd | Use of pharmaceutical combination |
GB0027357D0 (en) | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
BR0213155A (pt) * | 2001-10-10 | 2004-09-14 | Boehringer Ingelheim Pharma | Processamento de pó com fluidos gasosos pressurizados |
GB0125604D0 (en) * | 2001-10-25 | 2001-12-19 | Glaxo Group Ltd | Novel process |
AU2003210517A1 (en) * | 2002-02-04 | 2003-09-02 | Elan Pharma International, Ltd. | Drug nanoparticles with lysozyme surface stabiliser |
GB0202564D0 (en) * | 2002-02-04 | 2002-03-20 | Glaxo Group Ltd | Process |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
US20040109826A1 (en) * | 2002-12-06 | 2004-06-10 | Dey, L.P. | Stabilized albuterol compositions and method of preparation thereof |
US20040208833A1 (en) * | 2003-02-04 | 2004-10-21 | Elan Pharma International Ltd. | Novel fluticasone formulations |
EP1624862B1 (en) | 2003-05-08 | 2014-12-31 | Nektar Therapeutics | Particulate materials |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20060009435A1 (en) * | 2004-06-23 | 2006-01-12 | Joseph Kaspi | Synthesis and powder preparation of fluticasone propionate |
WO2007009164A1 (en) | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Method of particle formation |
US10137083B2 (en) | 2006-03-07 | 2018-11-27 | SGN Nanopharma Inc | Ophthalmic preparations |
CA2645080A1 (en) * | 2006-03-07 | 2007-09-13 | Novavax,Inc. | Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same |
US11311477B2 (en) | 2006-03-07 | 2022-04-26 | Sgn Nanopharma Inc. | Ophthalmic preparations |
KR20080105174A (ko) * | 2006-04-03 | 2008-12-03 | 테바 파마슈티컬 인더스트리즈 리미티드 | 약물 미립자 |
WO2007134845A2 (en) * | 2006-05-18 | 2007-11-29 | Synthon B.V. | Olanzapine pharmaceutical composition |
US20080138409A1 (en) * | 2006-09-29 | 2008-06-12 | Osinga Niels J | Olanzapine pharmaceutical composition |
GB0702402D0 (en) | 2007-02-08 | 2007-03-21 | Thar Pharmaceuticals Inc | Method of creating crystalline substances |
CA2677838C (en) | 2007-02-11 | 2017-08-01 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
US8088824B2 (en) * | 2007-08-15 | 2012-01-03 | Reata Pharmaceuticals Inc. | Forms of CDDO methyl ester |
JP2010111592A (ja) * | 2008-11-04 | 2010-05-20 | Aska Pharmaceutical Co Ltd | プロピオン酸フルチカゾンを含む局所投与剤 |
EP2435027B1 (en) | 2009-05-27 | 2016-10-05 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate meloxicam compositions |
US9012511B2 (en) | 2010-05-19 | 2015-04-21 | Alkermes Pharma Ireland Limited | Nanoparticulate cinacalcet compositions |
MX350838B (es) | 2011-02-11 | 2017-09-18 | Grain Proc Corporation * | Composicion de sal. |
AU2012282936B2 (en) * | 2011-07-08 | 2016-11-10 | Pfizer Limited | Process for the preparation of fluticasone propionate form 1 |
EP2802314B1 (en) * | 2012-01-13 | 2020-11-25 | XSpray Microparticles AB | A method for producing stable, amorphous hybrid nanoparticles comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix- forming component. |
US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
EP2847207B1 (en) | 2012-05-08 | 2019-03-27 | Nicox Ophthalmics, Inc. | Fluticasone propionate nanocrystals |
US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
CN104004044A (zh) * | 2013-02-25 | 2014-08-27 | 武汉诺安药业有限公司 | 高纯度丙酸氟替卡松制备方法 |
EP3508196B1 (en) | 2014-08-18 | 2021-07-14 | Alkermes Pharma Ireland Limited | Aripiprazole prodrug compositions |
US10016415B2 (en) | 2014-08-18 | 2018-07-10 | Alkermes Pharma Ireland Limited | Aripiprazole prodrug compositions |
CN108066329B (zh) * | 2016-11-11 | 2021-11-16 | 江苏恒瑞医药股份有限公司 | 一种吸入用氟替卡松或其衍生物的微粒的制备方法 |
WO2021219230A1 (en) | 2020-04-30 | 2021-11-04 | Paolo Fiorina | Antiviral treatment |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CY1291A (en) | 1980-02-15 | 1985-10-18 | Glaxo Group Ltd | Androstane 17 beta carbothioates |
JPS56138200A (en) * | 1980-02-15 | 1981-10-28 | Glaxo Group Ltd | Androstane carbothioate compound |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5658549A (en) | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
GB9313650D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
-
1996
- 1996-10-24 GB GBGB9622173.4A patent/GB9622173D0/en active Pending
-
1997
- 1997-10-23 AT AT97909496T patent/ATE240345T1/de not_active IP Right Cessation
- 1997-10-23 DK DK97909496T patent/DK0937100T3/da active
- 1997-10-23 CA CA002269134A patent/CA2269134C/en not_active Expired - Fee Related
- 1997-10-23 US US09/284,245 patent/US6406718B1/en not_active Expired - Fee Related
- 1997-10-23 JP JP10519130A patent/JP2001502350A/ja not_active Withdrawn
- 1997-10-23 EP EP97909496A patent/EP0937100B1/en not_active Expired - Lifetime
- 1997-10-23 PT PT97909496T patent/PT937100E/pt unknown
- 1997-10-23 AU AU47171/97A patent/AU4717197A/en not_active Abandoned
- 1997-10-23 WO PCT/GB1997/002929 patent/WO1998017676A1/en active IP Right Grant
- 1997-10-23 DE DE69722023T patent/DE69722023T2/de not_active Expired - Lifetime
- 1997-10-23 ES ES97909496T patent/ES2198555T3/es not_active Expired - Lifetime
-
1998
- 1998-04-28 PE PE1998000323A patent/PE68099A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB9622173D0 (en) | 1996-12-18 |
ES2198555T3 (es) | 2004-02-01 |
CA2269134C (en) | 2007-01-09 |
WO1998017676A1 (en) | 1998-04-30 |
PT937100E (pt) | 2003-09-30 |
CA2269134A1 (en) | 1998-04-30 |
JP2001502350A (ja) | 2001-02-20 |
DE69722023D1 (de) | 2003-06-18 |
ATE240345T1 (de) | 2003-05-15 |
PE68099A1 (es) | 1999-07-19 |
EP0937100A1 (en) | 1999-08-25 |
US6406718B1 (en) | 2002-06-18 |
AU4717197A (en) | 1998-05-15 |
DE69722023T2 (de) | 2004-04-08 |
EP0937100B1 (en) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0937100T3 (da) | En ny polymorfisk krystallinsk form af fluticasonpropionat, fremgangsmåder til fremstilling deraf og farmaceutiske præparater deraf | |
IS5500A (is) | Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum | |
NO993847D0 (no) | Fremgangsmåter og sammensetninger for behandling av allergisk astma og andre sykdommer som anvender deskarboetoksyloratadin | |
DE60117615D1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
NO20002835D0 (no) | 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor | |
NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
ATE288489T1 (de) | Vp-antigene des jc-virus | |
NO994613D0 (no) | Fremgangsmaate og preparat til behandling av sövn-apne | |
KR970704430A (ko) | 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity) | |
NO165547C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive androsta-1,4-dien-3,17-dioner. | |
TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
FI972697A0 (fi) | Inhalaatiolaite, menetelmä farmaseuttisesti vaikuttavan aineen dispergoimiseksi ja menetelmä farmaseuttisesti vaikuttavan aineen annoksen jakamiseksi | |
IT9048260A0 (it) | Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. | |
IS2788B (is) | Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar | |
EP0907369A4 (en) | MATERIALS AND METHODS FOR TREATING MULTIPLE DISEASES | |
IS5409A (is) | Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau | |
EP0755372A4 (en) | INHIBITORS OF THE NEURAMINIDASE OF THE FLU VIRUS AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
NO20010277D0 (no) | Benzocykloheptener, fremgangsmåte for fremstilling derav, farmasöytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter | |
IS1571B (is) | Aðferð til framleiðslu á afleiðum tetralíns, cromans og skyldra efnasambanda til meðferðar á asma, liðagigt og skyldum sjúkdómum | |
LTIP863A (en) | Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases | |
IT9048261A0 (it) | Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. | |
AU3703900A (en) | Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders | |
IL125446A0 (en) | Pharmaceutical composition for the treatment of asthma allergy and inflammation | |
NO983465L (no) | Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser |